The Valley Desk

NCT05457283 · Interventional trial

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

Overall registry status Recruiting

Phase 3

Conditions Children, Chronic Kidney Disease, Proteinuria

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov